Enkuo Zheng
Overview
Explore the profile of Enkuo Zheng including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
47
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang M, Li X, Cai C, Liu C, Ma M, Qu W, et al.
Eur Radiol
. 2023 Dec;
34(7):4352-4363.
PMID: 38127071
Objectives: This study aims to develop and validate a radiomics model based on F-fluorodeoxyglucose positron emission tomography-computed tomography ([F]FDG PET-CT) images to predict pathological complete response (pCR) to neoadjuvant chemoimmunotherapy...
2.
Sun J, Zhao W, Zhang C, Zheng E, Jiang X, Wang L, et al.
Transl Lung Cancer Res
. 2023 Aug;
12(7):1611-1624.
PMID: 37577314
Background: Bronchiolar adenoma (BA)/ciliated muconodular papillary tumor (CMPT) is a rare lung tumor characterized by ciliated, mucous and basal cells. Recently, some cases of driver mutations or malignant transformations have...
3.
Zhao W, Chu M, Ma L, Minervini F, Molnar T, Zheng E, et al.
J Thorac Dis
. 2023 Aug;
15(7):4027-4032.
PMID: 37559653
Background: Impaling injuries to the chest are relatively rare and often lethal. Initial evaluation, resuscitation, and surgical planning can be challenging for emergency physicians and surgeons. Chest trauma can be...
4.
Zhu H, Xu X, Zheng E, Ni J, Jiang X, Yang M, et al.
Oncol Rep
. 2022 Jul;
48(3).
PMID: 35866595
Lung adenocarcinoma (LUAD) is the most common lung cancer with high incidence. The prognosis of LUAD is poor due to its aggressive behavior. Long non‑coding RNAs (lncRNAs) have been reported...
5.
Yang M, Zheng E, Ni J, Xu X, Jiang X, Zhao G
Tissue Cell
. 2022 Jan;
75:101702.
PMID: 35038619
Purpose: Circular RNAs (circRNAs) have emerged as a pivotal regulatory element in the progression of human cancers. Being an important member of circRNAs, circFOXO3 has been implicated in tumor invasion...
6.
Ni J, Yang L, Zhu H, Chu M, Zhang C, Zhao W, et al.
Ann Palliat Med
. 2021 May;
10(4):4999-5009.
PMID: 33966436
Lung cancer is a malignancy with the highest morbidity and mortality in the world. Radiotherapy, chemotherapy, targeted therapy, and immunotherapy have been widely used to treat metastatic non-small cell lung...
7.
Zhao G, Jiang X, Wang F, Chu M, Zhang C, Zhao W, et al.
J Thorac Dis
. 2021 Jan;
12(12):7346-7354.
PMID: 33447424
Background: High-position single-intercostal two-port video-assisted thoracic surgery (VATS) technique has been used for thoracic diseases. It can effectively avoid postoperative chronic pain compared with the traditional three-port VATS. This study...
8.
Zheng E, Yang M, Li R, Ni J, Xu X, Zhao G
J Thorac Dis
. 2020 Jul;
12(5):2049-2060.
PMID: 32642107
Background: Lymphadenectomy is an important part of surgical treatment for non-small cell lung cancer (NSCLC). However, the prognostic impact of lymph node (LN) dissection for patients with NSCLC ≤1 and...
9.
Shen H, Zheng E, Yang Z, Yang M, Xu X, Zhou Y, et al.
Oncol Lett
. 2020 Jun;
20(1):43-52.
PMID: 32565932
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-associated mortality worldwide. yrdC N6-threonylcarbamoltransferase domain containing protein (YRDC) has been demonstrated to be involved in the formation of threonylcarbamoyladenosine...
10.
Xu X, Zhu H, Yang M, Zheng E, Zhou Y, Ni J, et al.
Exp Ther Med
. 2020 Feb;
19(3):1925-1932.
PMID: 32104250
Non-small cell lung cancer (NSCLC) is one of the most common cancer types worldwide. Previous studies have indicated that TOR signaling pathway regulator (TIPRL) is involved in the progression of...